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Mastitis is an inflammatory disease of bovine mammary glands and is the most 
economically important disease affecting dairy herds in South Africa, and globally. The 
incidence and history of mastitis in South Africa has been extensively documented 
and found to be bacterial in origin. Streptococcus uberis (S. uberis) is the most 
common environmental causal agent of mastitis from clinical and subclinical samples 
in several countries, including Australia, the United Kingdom, New Zealand, and 
Belgium. Due to the causal agents ability to exist in cells, it remains protected from 
antibiotics. The quest for antibiotic free dairy management has funded the research 
into integrated strategies, predominantly proactive udder health management. 
Biological control methods are not widely used, specifically the use of bacteriophage 
(phage) therapy. Phages are ubiquitous (found in all biospheres) and are the most 
abundant organisms on earth. Understanding the interaction between phages and 
their hosts is vital to their manipulation for therapeutic conditions. 
This study aimed to isolate phages from unpasteurized milk of dairy cows, sequentially 
screened these against S. uberis isolates demonstrating antimicrobial resistance at 
the time. The phages have been screened for robust lytic characteristics for the of 
intent of a phage-based therapy.  
Bacterial strains of S. uberis were isolated from unpasteurized milk by Allerton 
laboratories submitted by dairy farms in KwaZulu-Natal, South Africa. The samples 
were screened for S. uberis using the following tests: haemolysis patterns on blood 
agar, catalase reactions using hydrogen peroxide (5%), and Gram reaction. The 
identity of the strains was then confirmed by Inqaba Biotechnical Industries (Pty) Ltd 
via sequencing of the 16s ribosomal RNA. 
The six S. uberis strains were screened against 8 commonly used antibiotics in the 
dairy industry: β-lactam (ampicillin, penicillin G, cefalexin, oxacillin and amoxicillin), 
macrolides (erythromycin), tetracyclines (tetracycline) and glycopeptide (vancomycin). 
Using the Kirby Bauer method and The European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) clinical breaking points zone diameters, version 10.0, 
2020. Every strain of S. uberis was susceptible to vancomycin, which is not available 
for intra-mammary infections. Resistance to the 7 other antibiotics varied amongst the 
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strains. This was not a survey study but an isolation of S. uberis strains to challenge 
the efficacy of phage therapy.  
Approximately 2,000 mastitic milk samples were screened for phages resulting in the 
isolation of 95 phages. This was further reduced by screening for constant lytic ability 
to five phages that were characterized for their phage titre, host range, single step 
growth phase and lethal dose activity. The titre of the five selected phages varied 
considerably. Phages CP1, CP2, CP76, CP79 and CP80 produced titres of 59x102, 
56x105, 47x106, 50x104 and 35x104 pfu.ml-1, respectively. There was a differential 
interaction between the five phages isolates and the six strains of S. uberis. One strain 
of S. uberis was susceptible to all five phages, Strain 21A, whereas Strains 17D and 
78B were not susceptible to any of the five phages. Phage CP2 was virulent to four of 
the six S. uberis strains.  The single step growth assay illustrated the cyclic replication 
of the isolated phages takes between 50 - 60 minutes. In a lethal dose assay, Phages 
CP1 and CP2 were each able to reduce S. uberis counts by 86% and 83%, 
respectively. Of the 5 phages screened Phages CP1 and CP2 showed potential as 
stand-alone treatments, whereas Phages CP76, CP79 and CP80 would offer better 
control when combined in a phage cocktail, and this would broaden the host range. 
Phage samples were examined using transmission electron microscopy (JEOL 1400). 
Various negative stains were used to view the virus particles: 2% uranyl acetate (UA), 
2% phosphotungstic acid (PTA) and 0.05-5% ammonium molybdate (AM). The AM 
staining provided the best images of infected bacterial cells and phage surface 
structures. All micrographs obtained, illustrated similar viral particle structures 
suggesting the phages screened belong to one family.  A virus particle was measured 
to have a 50-65nm diameter icosahedral head and a short tail ranging from 25-35nm 
in length from the EM micrograph. The virus particles exhibited Podoviridae 
morphology. However, only a complete genomic sequencing will confirm the identity 
of these virus particles to a species level.  
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Bovine mastitis is caused by numerous pathogens including mycoplasma, viruses, 
yeasts and algae with the most prominent being bacteria (Batavani et al., 2007). The 
etiological agents of mastitis vary amongst countries, depending on the climate, animal 
species and husbandry practices (Watts, 1988; Bradley, 2002). In most cases, the 
causal agent of mastitis in Africa are of bacterial origin (Bradley, 2002). 
Apart from reducing the milk yield by up to 30%, mastitis has a detrimental effect on 
milk composition and its physicochemical constitution (Batavani et al., 2007). The 
change is a result of the mammary gland being infected, resulting in inflammation, and 
abnormal cell and enzyme activity (Walstra et al., 2006). Mastitis also changes the 
concentration and quality of protein that would normally be present in a healthy cow 
(Ogola et al., 2007). Furthermore, undesirable enzymes that are produced in excess 
during infection reduces the quality of milk and its production value (Ogola et al., 2007). 
The accumulation of detrimental traits lowers the value of milk to the point where it 
becomes unmarketable, thereby incurring losses to the farmer (Bradley, 2002; 
Batavani et al., 2007).  
Previously antibiotics were not only used in the presence of a bacterial infection but 
as a preventative measure during the drying off period (Blowey and Edmondson, 
2010). The antibiotics tetracycline and streptomycin are commonly administered to 
herds during the dry periods as a precautionary step (Barkema et al., 2006; Call et al., 
2008; Oliver et al., 2011). The continuous use of antibiotics as a preventative measure 
has previously been documented by Oliver et al. (2011), to be a causal agent of the 
emergence of bacterial drug resistance in mastitic pathogens. However, Karzis et al. 
(2018) reported no increase of bacterial resistance in the South African dairy industry 
for the last 10 years. 
The long-term and frequent use of antibiotics as the sole control measure used to 
manage mastitis inevitably leads to antibiotic resistance on dairy farms. It cannot be 
seen as abuse or misuse, given that antibiotic use is strictly controlled by veterinarians 
depending on the country’s regulatory laws, it is simply bacterial evolution in action. 
Although bacterial resistance is not a current problem in the South African dairy 
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industry. There is great urgency to develop alternative therapies to alleviate the 
diminishing efficacy of antibiotics worldwide reported by Vanderhaeghen et al. (2010). 
The widespread development of multidrug-resistant bacteria such as Pseudomonas 
spp. (Ahmad et al., 2002), Klebsiella pneumonia (Vinodkumar et al., 2005), 
Escherichia coli (Blowey and Edmondson, 2010), vancomycin-resistant Enterococci 
(Biswas et al., 2002) and Staphylococci (Blowey and Edmondson, 2010), and 
methicillin-resistant Staphylococcus aureus (Basdew and Laing, 2011), has led the 
Western countries to renew their research programmes into phage therapy. 
Phages are naturally occurring viruses that are a part of the microbial ecosystem, with 
the natural environment containing billions of phages (Chanishvili et al., 2001; Garcia 
et al., 2009). Phages have specific bacterial hosts and can infect bacteria without 
harming the plant or animal host of the bacterium (Fischetti, 2005).  
In the global food industry, phages are being developed as alternatives to disinfectants 
(Sofos, 2008). Since 2006, phage applications have been approved by legislation for 
the elimination of Listeria monocytogenes (Sofos, 2008).  
The objective of this project was to isolate and characterise phages capable of lysis of 
in vitro bovine S. uberis. The research was envisaged as a precursor to in vivo trials 
on dairy herds, to support or replace antibiotic therapy. The specific research 
objectives of the current study were therefore as follows: 
1. Review of literature on the impact of bovine mastitis on the dairy industry, the 
nature of the mastitis infection and the cow’s defence mechanisms, the history 
and evolution of antibiotic resistance in the dairy industry and the potential of 
phage therapy in dairy production.  
2. Identify resistant S. uberis strains present in KwaZulu-Natal (KZN) to access 
the phage therapy efficacy in chapter 3. 
3. Isolate, screen and characterize S. uberis phages in the following categories: 
phage titre, host range, single step growth phase and lethal dose activity.  
4. Morphologically characterise the S. uberis phages using a transmission 
electron microscopy (JEOL 1400). 
This dissertation comprises five chapters; one is a literature review, three are 
research chapters on the isolation of S. uberis strains and phages, following the 
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characterization of antibiotic resistance and phage lytic ability. The final chapter is 
an overview of the research covered in the dissertation, identifying key findings 
and future research. Each chapter is written in the form of a scientific paper. As a 
result, there is some unavoidable repetition of prior information and references. 
However, this is the recommend format adopted by the University of KwaZulu-
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Review of Literature 
1.1 Introduction  
Bovine mastitis is an inflammation of the parenchyma of mammary glands of dairy 
cows (Jones and Bailey, 2009). The symptoms comprise of physical and chemical 
changes of the glandular tissue and of milk, adversely affecting the cow’s health and 
quality of milk respectively (Blowey and Edmondson, 2010). The variety of pathogens 
that can infect a cow’s udder was demonstrated by Watts, who isolated and identified 
137 different pathogens from mastitis-infected cows (Watts, 1988). Contamination 
may originate from numerous sources in the milking process and housing of the cow, 
including contaminated milking equipment, staff and unsanitary stalls (Watts, 1988; 
Bradley, 2002). The etiological agents of mastitis vary between countries, depending 
on the climate, animal species and husbandry practices (Watts, 1988; Bradley, 2002). 
The ubiquity of these pathogens, coupled with the endemic nature of the disease, 
makes complete eradication impossible (Blowey and Edmondson, 2010). Mastitis is 
recognized as a disease complex, which is a disease involving various factors. 
Identifying the main pathogens and risk factors are fundamental to developing 
preventive and control measures (Harding, 1995; Van den Borne, 2010). The common 
causal agents of mastitis in Africa are of bacterial origin, with five common species: 
Escherichia coli, Streptococcus uberis, Streptococcus dysgalactiae, Streptococcus 
agalactia and Staphylococcus aureus (Bradley, 2002).  
Mastitis is the most economically important disease affecting dairy herds worldwide, 
with losses arising from decreased milk production, reduced milk quality, veterinary 
bills and culling (Batavani et al., 2007; Kudi et al., 2009). Clinical mastitis costs the UK 
dairy industry an excess of USD 192 million annually (Bradley, 2002). In 1976, annual 
losses from mastitis in the USA were estimated at a total of USD 1,294 million and 
these losses had increased to USD 2 billion by 2009 (Viguier, 2009). Worldwide 
collective mastitis losses are estimated to be USD 35 billion annually (Jones and 
Bailey, 2009; Van den Borne, 2010). 
A mastitis infected cow is usually treated with antibiotics to eliminate the infection as 
the first defense dependent of the bacterial species (Reyher and Dohoo, 2011). 
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However, milk containing quantities of antibiotic residues exceeding the regulated limit 
will be dumped, causing further financial losses to the already incurred reduced milk 
turn-over, culling and veterinary expenses attributed to mastitis (Reyher and Dohoo, 
2011). The adverse effects are not limited to financial losses. Extensive use of 
antibiotics in the treatment of mastitis increases the probability of creating antibiotic-
resistant strains of the causal bacterium (Mangili et al., 2005; Shi et al., 2010). The 
inevitable development of antibiotic resistance has driven a search for alternative 
control measures to manage the disease (Bradley, 2002).  
One such measure is the use of biological control to treat mastitis, specifically the use 
of phage therapy to treat pathogenic bacterial infections (Garcia et al., 2009; Basdew 
and Laing, 2011). Phage therapy targets a specific strain of bacterium and is harmless 
to the host and beneficial bacterium (Basdew and Laing, 2011), unlike antibiotics 
which have a wider target spectrum, other than the target pathogen (Chanishvili et al., 
2001). With the pressure of antibiotic resistance looming, the concept of phage therapy 
has grown in popularity (Chanishvili et al., 2001). Many phage applications are 
showing promise and have been approved against food pathogens (Hagens and 
Offerhaus, 2008). An example is Listex, a commercial phage therapy used in the 
United States against Listeria monocytogenes, a common food poisoning pathogen 
(Hagens and Offerhaus, 2008). Phage therapy is also regularly administered in 
Georgia, Poland and Russia on human pathogens that do not respond to antibiotic 
treatments (Fischetti, 2005). However, the development of phage therapy to manage 
mastitic bacteria has not reached the stage of registration yet (Garcia et al., 2009). 
This review covers the current developments in bovine mastitis, with a focus on the 




1.2 Mastitis  
Mastitis is a complex disease due to the number of etiological agents responsible for 
the disease. Hence, identifying the main causal agents is essential for control 
(Harmon, 1995; Van den Borne, 2010). Mastitis is classified into two dynamic groups, 
determined by the pathogen source and mode of transmission, i.e., contagious and 
environmental (Bradley, 2002). To date, more than 200 potentially pathogenic species 
of organisms have been shown to cause bovine mastitis (Watts, 1988; Petrovski et al., 
2011). There is a large number of less common pathogens that are difficult to 
categorise as environmental or contagious due to their varying characteristics (Blowey 
and Edmondson, 2010). Contagious mastitis is further subdivided into clinical mastitis, 
sub-clinical mastitis and chronic mastitis (Bradley, 2002; Jones and Bailey, 2009). 
Clinical mastitis is characterized by systemic symptoms (change in behaviour, loss of 
appetite, fever), inflammation of the udder and a visual change in the composition of 
the milk (Kudi et al., 2009). Sub-clinical mastitis results in a change in milk composition 
without visual symptoms on the infected udder such as inflammation or milk 
abnormalities (Batavani et al., 2007).  Chronic mastitis comprises a mixture of 
symptoms that occur periodically (Bradley, 2002).   
 
1.2.1 Contagious Pathogens  
Contagious pathogens are primarily located on the teat of the cow, which then serves 
as a reservoir of infection, resulting in microbes spreading from one cow to the next 
during milking (Kudi et al., 2009). Contagious pathogens include Staphylococcus 
aureus, Streptococcus agalactia, Mycoplasma spp. and Corynebacterium bovis 
(Bradley, 2002; Jones and Bailey, 2009). There is a large number of less common 
pathogens that are difficult to categorise as environmental or contagious due to their 
varying characteristics (Blowey and Edmondson, 2010).  
 
1.2.2 Environmental Pathogens  
Environmental pathogens are pathogens that do not ordinarily live on the animal; but 
are introduced onto the teat of the cow from the environment (Blowey and Edmondson, 
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2010). These pathogens may be transferred from the bedding material, faecal matter, 
feed or workers (Kudi et al., 2009). The most frequently isolated environmental 
pathogens are usually Staphylococcus uberis, Escherichia coli, Klebsiella spp. and 
Enterobacter spp, (Bradley, 2002; Kudi et al., 2009; Blowey and Edmondson, 2010).  
The incidence of these pathogens fluctuates with time and correlates with a decrease 
in Staphylococcus aureus diagnoses (Blowey and Edmondson, 2010).  
 
1.3 Prominent Etiological Agents of Mastitis  
1.3.1 Staphylococcus aureus 
This bacterium is Gram-positive, coccus-shaped, haemolytic and a facultative 
anaerobe (Madigan et al., 2012). S. aureus was the most prominent etiological agent 
of clinical and subclinical mastitis cases found in dairy herds globally and is classified 
as a contagious pathogen (Workineh et al., 2002; Barrett et al., 2005; Jones and 
Bailey, 2009; Basdew and Laing, 2011). Recent studies have reported 10% of mastitis 
cases have been linked S. aureus (Karzis et al., 2018).  
The development of antibiotic resistance in S. aureus has been well documented and 
makes the control of mastitis outbreaks difficult and ineffective (Basdew and Laing, 
2011). Many dairy farmers have implemented mastitis prevention programmes to 
avoid S. aureus outbreaks (Bradley, 2002; Barkema et al., 2009). The reason for the 
poor response to antibiotic therapy is due to the biological functions of the bacterium 
(Bradley, 2002). Antibiotics circulate within the bodily fluids but are unable to penetrate 
cells (Barkema et al., 2009). In contrast, S. aureus can penetrate and live within 
macrophages, out of reach of antibiotics (Barkema et al., 2009). Once an S. aureus 
infection is established within the mammary tissue, it forms a fibrous wall around itself 
that is almost impermeable to antibiotics (Workineh et al., 2002). These two 
characteristics result in chronic, recurring episodes of mastitis in specific cows, which 
show limited responsiveness to treatment (Workineh et al., 2002; Barkema et al., 
2009). Methicillin-resistant S. aureus (MRSA) is one of the popular public health 
concerns associated with bovine mastitis (Workineh et al., 2002; Barkema et al., 
2009). Due to the zoonotic transmission possibility, MRSA poses a great risk to the 
human population (Barkema et al., 2009).  
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1.3.2 Streptococcus agalactiae  
Streptococcus agalactiae is a Gram-positive, coccus-shaped, β-haemolytic bacterium 
(Madigan et al., 2012). It is classified as a contagious pathogen because the primary 
source of infection is within the mammary gland, the teat canal and the teat skin 
(Barkema et al., 2009). Developed countries have been able to eliminate S. agalactiae 
from dairy herds by adhering to recommended control strategies (Andersen et al., 
2003; Olde Riekerink et al., 2006). It is responsive to antibiotic therapy although being 
highly contagious, resulting in the marked success rate of elimination from dairy herds 
(Olde Riekerink et al., 2006). If S. agalactiae is present in a dairy herd, it is a general 
indicator of poor hygiene during the milking process (Andersen et al., 2003).   
 
1.3.3 Streptococcus dysgalactiae  
Streptococcus dysgalactiae is a Gram-positive, coccus-shaped, β-haemolytic 
bacterium (Madigan et al. 2012). It is both environmental and contagious as the 
pathogen can be transmitted during milking and can be found on organic matter in the 
general vicinity of the animal (Barkema et al., 2009). Successful treatment of S. 
dysgalactiae is common with the use of broad-spectrum intermammary antibiotics 
(Nickerson, 2009). Sanitary precautions and proper milking procedures increase the 
probability of prevention of this pathogen (Nickerson, 2009).     
 
1.3.4 Escherichia coli  
Escherichia coli causes both a non-persistent and persistent intermammary infection 
(Blowey and Edmondson, 2010). In non-persistent cases, the infection undergoes self-
cure (Blowey and Edmondson, 2010). The symptoms exhibited are largely dependent 
on the host characteristics. Predominantly, the symptoms are a hard, hot, swollen 
quarter, with a watery discharge (Burvenich et al., 2003). Cases of cows dying from a 
shock reaction due to an E. coli infection is a result of an endotoxin (Burvenich et al., 
2003). Responses to antibiotic treatment of this bacterium varies, depending on the 
type strain present, due to its genetic diversity (Burvenich et al., 2003). Some strains 
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have demonstrated increased resistance to some antibiotic groups: tetracycline, β-
lactam agents and lincomycin (Burvenich et al., 2003). 
 
1.3.5 Streptococcus uberis 
Streptococcus uberis is a Gram-positive, coccus-shaped, non-haemolytic bacterium 
that causes environmental bovine mastitis (Madigan et al., 2012). This bacterium is 
capable of both clinical and subclinical infections of cows (Almeida et al., 2006).  
“S. uberis has been repeatedly identified as the most commonly isolated pathogen 
from clinical and subclinical samples in several countries, including Australia, the 
United Kingdom, New Zealand, and Belgium”, (Davies et al., 2016). S. uberis has been 
documented to show little responsiveness to antibiotic treatments (Burvenich et al., 
2003; Blowey and Edmondson, 2010). Compounded with its ability to move into the 
lymph nodes, it is a persistent nuisance to the dairy community (Almeida et al., 2006; 
Nickerson, 2009). The pathogen is extremely versatile and is able to survive in various 
areas of cows: mouth, vulva, groin and axilla (Almeida et al., 2006; Blowey and 
Edmondson, 2010). The bacterium is identified as an environmental pathogen and is 
found in the bedding (straw and sand), pastures and faeces (Almeida et al., 2006; 
Blowey and Edmondson, 2010). Dairy cows are constantly exposed to S. uberis due 
to the ubiquity of the pathogen. Once cows are infected, the pathogen may behave as 
a contagious infection (Almeida et al., 2006). The symptoms include hard, swollen 
quarters, clotting of milk and a fever. S. uberis has been documented with a large 
strain diversity, varying in pathogenicity (Barkema et al., 2009). Some strains have 
also shown resistance to phagocytosis in the presence of the milk protein casein 
(Hillerton and Kliem, 2002). Originally S. uberis was classified an environmental 
pathogen of low importance (Erskine et al., 2002). Currently, the pathogen shows low 
sensitivity to antibiotic therapy, resulting in chronic and recurrent subclinical mastitis 
(Hillerton and Kliem, 2002). Thus, early detection of this pathogen is required to isolate 
infected animals to prevent further spread (Hillerton and Kliem, 2002). Due to its poor 
opsonization in the presence of casein protein and its ability to exist in cells, it remains 
protected from antibiotics (Hillerton and Kliem, 2002). S. uberis is the most common 
environmental mastitis pathogen in most countries (Barkema et al., 2009; Blowey and 
Edmondson, 2010).  
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1.3.6 Coagulase-Negative Staphylococci (CNS)  
Coagulase-negative staphylococci (CNS) are Gram-positive, coccus-shaped bacteria 
that can either be haemolytic or non-haemolytic, and are coagulase negative (Erskine 
et al., 2002). More than 50 species have been classified as CNS and can cause both 
clinical and subclinical mastitis (Pyörälä and Taponen, 2009; Thorberg, et al., 2009). 
The predominate CNS species identified causing intra-mammary infections were S. 
chromogenes, S. haemolyticus, S. simulans and S. epidermidis. Other CNS species 
identified at lower frequencies included S. hominis, S. auricularis, S. sciuri, S. 
capitis, S. cohnii, S. warneri, S. pasteuri, S. xylosus, S. hyicus, S. equorum, S. microti, 
S. rostri, S. gallinarum, S. saprophyticus and S. succinus (Jenkins et al., 2019; 
Taponen et al., 2008; Pyörälä; Taponen, 2009). In Belgium, S. chromogenes was 
documented to be the predominate CNS species (Jenkins et al., 2019). The 
occurrence of CNS in US and European dairy herds has been documented to infect 
up to 55% of the heard (Jenkins et al., 2019). Petzer et al., (2016) reported an isolation 
of CNS pathogens from 12.4% of quarters with high SCC in South African commercial 
dairy herds. They are commonly found in the environment, teat skin, teat ends, nasal 
passages and milker’s hands (Thorberg et al., 2009). Previously CNS infections 
underwent  self-cure, currently data shows an increased trend of occurrence rates and 
persistent infections ( Jenkins et al., 2019; Pyörälä and Taponen, 2009).  
 
1.4 Effect of Mastitis on Milk Composition 
Apart from reducing the milk yield by up to 30%, mastitis has a detrimental effect on 
milk composition and physicochemical constitution (Batavani et al., 2007). The change 
is a result of the mammary gland being infected, resulting in inflammation and 
abnormal cell and enzyme activity (Walstra et al., 2006). Internal swelling usually 
follows, and the mammary gland alveoli become structurally damaged (Schukken et 
al., 2004). The blood-milk barrier then becomes compromised, which leads to the 
release of unregulated chloride, sodium, hydrogen, potassium and hydroxide ions into 
the milk, thereby increasing the conductivity and pH of the milk (Schukken et al., 2004). 
Typical external symptoms of severe infection include swelling and reddening of the 
udder (Blowey and Edmondson, 2010). Milk also contains a higher water content and 
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visible blood and clots (Schukken et al., 2004). If left untreated, the infection may result 
in the animal’s death (Blowey and Edmondson, 2010). 
Lactose concentrations in milk of mastitis infected cows decrease, which results in 
increased sodium and chloride levels to maintain an osmotic balance (Blowey and 
Edmondson, 2010). These increases can be measured by the electrical conductivity 
(EC) of the milk because the increased concentrations of sodium and chloride ions 
increase the EC of the milk (Walstra et al., 2006). A high salt concentration imparts a 
salty, bitter taste to infected milk (Walstra et al., 2006; Blowey and Edmondson, 2010). 
Mastitis also changes the concentration and quality of protein present in milk. (Ogola 
et al., 2007). Casein is the primary protein present in milk that is required for cheese 
and yoghurt production (Ogola et al., 2007). A low concentration of casein affects the 
flavour and quality of cheese and yoghurt (Harmon, 1995; Ogola et al., 2007). 
Furthermore, undesirable enzymes that are produced in excess during infection 
reduce the quality of milk and its production value (Ogola et al., 2007). The enzyme 
plasmin, which degrades casein, has been found at higher levels after mastitis 
infection (Harmon, 1995). The enzyme is not denatured during pasteurization and is 
active during cold storage, reducing shelf life (Harmon, 1995). The enzyme lipase 
degrades fat in milk into fatty acids, which hinders starter cultures in cheese and milk 
production (Harding, 1995). Increased concentrations of free fatty acids also leads to 
a rancid flavour in milk (Harding, 1995). The accumulation of undesirable properties in 
contaminated milk caused by mastitis lowers the value of milk to the extent where it 
becomes unmarketable, thereby incurring direct financial losses to the farmer 
(Bradley, 2002; Batavani et al., 2007). 
 
1.5 Transmission of Mastitis 
The detailed epidemiology of mastitis will allow for further insight into the development 
of adequate detection and control techniques. The presence of lactose and the warm 
temperature of bovine mammary glands promotes rapid growth of Gram-negative, 
lactose-fermenting pathogens (Workineh et al., 2002; Barkema et al., 2009). The 
pathogen enters the teat of a cow from a reservoir that is either from the environment 
or introduced from another cow (Barkema et al., 2009). In the environment, these 
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pathogens are ever-present. However, it does not become problematic until 
environmental conditions favour the rapid population rise of one micro-organism 
(Madigan et al. 2012). Frequently encountered environmental pathogens that cause 
bovine mastitis are E. coli, S. uberis, Bacillus spp., fungi and yeasts which is variable 
depending on the climate, changing environmental conditions and farming strategies 
(Barkema et al., 2009; Madigan et al., 2012).  
The spread of pathogens between cows is generally through contaminated equipment 
or staff members, and these pathogens and are referred to as contagious (Blowey and 
Edmondson, 2010). Typical examples include S. aureus, S. agalactiae and S. 
dysgalactiae (Blowey and Edmondson, 2010). The contagious pathogens can also be 
introduced from new cows that are added to the herd (Barkema et al., 2009).  
The pathogen enters via the teat canal, which is naturally closed by a sphincter muscle 
as a defence response to pathogens (Dogan et al., 2006). However, after milking, the 
teat canal may remain dilated open for up to 120 minutes, and if damaged, the teat 
canal may remain partially open indefinitely, allowing pathogens to colonize the teat 
canal and mammary tissue (Barkema et al., 2009). Milking equipment may also propel 
the pathogen into the teat by a reverse flow of milk (Schukken et al., 2004; Dogan et 
al., 2006). If the pathogen can avoid the natural defence mechanisms (cellular and 
humoral) of the cow, it will establish itself inside the udder and will replicate 
exponentially (Schukken et al., 2004; Barkema et al., 2009). 
Research has shown that a dairy cow is increasingly vulnerable to intramammary 
infections during a number of physiological transitions including: as calving 
approaches, early non-lactating periods (drying off) and the early lactation periods 
(Nickerson, 2009). Understanding the periods of high susceptibility to infection and the 
life cycles of the causal agents has allowed for the appropriate preventative protocols 
to be established, thereby lowering disease incidence and ensuring stable production 




1.6 Teat and Udder Defense Mechanisms  
A cow’s mammary gland defence system employs a physical barrier and physiological 
mechanisms to alert the immune system of foreign bodies (Blowey and Edmondson, 
2010). The immune response is a multifaceted system comprising of a cellular 
response using leukocytes (granulocytes, lymphocytes and monocytes), and 
a hormonal response using soluble immune components such as antibodies and 
enzymes (Walstra et al. 2006; Blowey and Edmondson, 2010).   
 
1.6.1 Teat Defences  
The teat canal connects the teat orifice to the teat cistern which is a passageway that 
bacterial cells need to colonize or travel along in order to establish an infection (Fig. 
1.1) (Walstra et al. 2006; Blowey and Edmondson, 2010). The teat canal is lined with 
stratified squamous epithelium, (dead skin cells filled with keratin), which forms an 
impermeable physical barrier to bacterial cells, thus preventing their growth (Tyler and 
Ensminger, 1993). The entrance to the teat is sealed by a sphincter valve (Fig. 1.1), 
physically stopping the entry of foreign bodies (Juozaitiene et al., 2006). The teat canal 
ranges from 5-13 mm long and is lined with a bacteriostatic keratinised skin epidermis 
containing lipid keratin and cationic proteins (Seykora and McDaniel, 1985; 
Juozaitiene et al., 2006). The keratin fatty acids are bacteriostatic, with cationic 
proteins attached to them (Tyler and Ensminger, 1993). The proteins bind and break 
down Gram-positive bacterial cell walls, killing the bacteria (Tyler and Ensminger, 
1993). A forced purge of the teat canal occurs post-milking to push out any bacterial 
cells that may have entered because the canal remains dilated during milking (Seykora 
and McDaniel, 1985). Specialised cells in the teat canal called the Rosette of 
Furstenberg, release lymphocytes as a precautionary function after milking 
(Juozaitiene et al., 2006). After the lactation period, teats secret a waxy keratin plug 
which seals the teat end and acts as a physical barrier assisting the sphincter muscle, 
but this eventually dissolves as calving approaches (Seykora and McDaniel, 1985; 
Tyler and Ensminger, 1993). 
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Figure 1.1 The bovine udder and teat structure (Blowey and Edmondson, 2010). 
 
1.6.2 Udder Defences 
Infectious bacteria and fungi may circumvent the teat physical barriers and establish 
colonies in the mammary tissue (Walstra et al. 2006). This may occur by colonization 
of the teat canal after milking, or by direct inoculation via propulsion into the teat 
through reverse flow during milking (Blowey and Edmondson, 2010). Once a bacterial 
infection is established in the mammary gland, it will trigger a dual phase defence 
mechanism. The immune response occurs as an intrinsic defence that is continuously 
present as a precautionary mechanism, and secondly, as an inducible response that 




1.6.2.1 Intrinsic Defence  
The intrinsic defence system utilizes a multifaceted array of enzymes, antibodies and 
cellular responses to initiate defence (Walstra et al. 2006).  
Lactoferrin is an enzyme that binds to iron in udder secretions, reducing the 
availability of it to bind with citrate and become biological available to pathogenic 
bacteria (Leitner et al., 2000). The effects of lactoferrin are reduced during lactation 
but are mostly active during the non-lactating periods (Leitner et al., 2000; Walstra et 
al. 2006).  
Lactoperoxidase is an enzyme impedes the growth of Gram-positive bacteria 
and kills Gram-negative bacterium (Leitner et al., 2000; Walstra et al., 2006). 
Lactoperoxidase works in direct conjunction with thiocyanate and hydrogen peroxide, 
i.e., the higher the levels of thiocyanate and hydrogen peroxide, the more effective 
lactoperoxidase is (Blowey and Edmondson, 2010). 
Antibodies are present in high levels in the colostrum, and function by binding 
to antigen receptors on the bacterium (Blowey and Edmondson, 2010). This binding 
process triggers a response from white blood cells to engulf the identified bacterium 
increasing the efficacy of this immune reaction (Petzl et al., 2008). 
Somatic cells are present in the mammary tissue, and function by killing 
bacteria, thereby preventing infection (Sutra and Poutrel, 1994). Typical somatic cells 
induce neutrophils, vacuolated macrophages, non-vacuolated macrophages, 
lymphocytes and duct cells. A total cell count of somatic cells is termed the somatic 
cell count (SCC) (Sutra and Poutrel, 1994; Petzl et al., 2008). These cells vary in 
concentration, depending on the stage of lactation and the presence pathogens. They 
function as triggers of the immune system upon recognition of an infection, leading to 




1.6.2.2 Induced Defence  
The induced defence is a response to the presence of an infection that has overcome 
the intrinsic defence (Leitner et al., 2000). This response elicits multiple immune 
reactions to curb the infection (Leitner et al., 2000; Blowey and Edmondson, 2010).  
The chemotaxin alarm is the signal triggered by the detection of metabolic by-products 
of bacterial replication within the udder (Petzl et al., 2008). By-products released 
during phagocytosis of the bacterium by macrophages, and polymorphonuclear 
leucocytes, are also known to trigger an immune response (Petzl et al., 2008).  
The inflammatory response is the immune reaction signalled by the chemotaxin alarm 
(Blowey and Edmondson, 2010). It redirects the polymorphonuclear leucocytes 
present in blood vessels in the teat to the cistern and ducts of the mammary tissue 
(Juozaitiene et al., 2006; Petzl et al., 2008). The quarter that triggered the 
inflammatory response will become swollen and painful due to the increased blood 
flow (Petzl et al., 2008). Blood vessels increase in diameter, increasing the blood 
supply and the numbers of polymorphonuclear leucocytes that are delivered to the 
infection site (Walstra et al. 2006). Polymorphonuclear leucocytes move through the 
capillaries, across the mammary tissue and into the site of infection to engulf the 
bacteria (Walstra et al. 2006). The increase in the number of cells in milk due to the 
inflammatory response is exponential from a base level (Blowey and Edmondson, 
2010). The induced response, including inflammation and a high SCC, will persist for 
a short period after the bacteria have been destroyed (Walstra et al. 2006). 
 
1.7 Antibiotic Treatment of Dairy Herds 
The lack of data correlating antibiotic resistance development and increased 
susceptibility to mastitis is another obstacle to the development of alternative 
treatment therapies in South Africa. Whilst the zoonotic potential of the bovine mastitis 
pathogens has not been clearly documented, it is a cause for growing concern as more 
species develop antibiotic resistance (Oliver et al., 2011). Methicillin-resistant S. 
aureus (MRSA) is a widely spread pathogen of humans and cows. MRSA contains the 
gene mecA which confers high levels of resistance to β-lactams (Vanderhaeghen et 
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al., 2010). Cases of MRSA associated with bovine mastitis have been documented in: 
Switzerland, Korea, Germany, Belgium, Switzerland, Japan and Turkey, where it has 
been found that the horizontal transfer of multi-antibiotic resistant genetic material 
between human and bovine strains of MRSA was possible (Vanderhaeghen et al., 
2010). The rise of antibiotic-resistant pathogens has led to the search for viable 
alternatives to antibiotic therapy. Staphylococcal chromosomal cassettes (SCCs), 
which vary in size, usually contain additional genetic information, including genes 
encoding resistance to multiple classes of antimicrobials (Morgan, 2008). The smallest 
cassette containing a mecA gene, SCCmec type IV, is present in clones of CA-MRSA, 
which are becoming endemic in many parts of the world, excluding Africa (Morgan, 
2008). Morgan, (2008) reported MRSA ST398 infection locations which has zoonotic 
risk as sporadic in livestock in the Netherlands and France (Morgan, 2008). Springer 
et al. (2009) stated, "Evidence has also identified a link between colonization of 
livestock and MRSA carriage and infections in people who work with animals”, in 
Europe. MRSA as not been seen as a zoonotic threat historically, yet strain ST398 is 
showing a high percentage of lineage strains in Austria (Springer et al., 2009). The 
main concern would be the spread of the ST398 lineage across livestock industries 
via reverse zoonosis or introduced into the health care sector (Springer et al., 2009).  
 
1.8 Antibiotic Resistance Screening 
The discovery of the first antibiotic in the 1920s has played a pivotal role in the 
treatment of pathogenic diseases of mammals (Blowey and Edmondson, 2010). Since 
then antimicrobial chemotherapy research has yielded a plethora of antimicrobial 
agents currently employed for clinical use.   
The Kirby Bauer disc diffusion method allows for the identification of bacterial 
resistance to a range of antibiotics (Bauer et al., 1966). This method involves 
measuring the inhibition zones created by antibiotic infused discs placed onto the 
surface of inoculated agar. Using a reference table, the size of the inhibition zone can 
determine if the bacterium is susceptible (S), intermediately susceptible (I), or resistant 
(R) to that antibiotic (Bauer et al., 1966). The European Committee on Antimicrobial 
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Susceptibility Testing (EUCAST) is an example of clinical breaking points zone 
diameters constantly being evaluated. 
 
1.9 Alternative Therapies  
A variety of alternative therapies are currently being investigated, as the world moves 
towards a more proactive stance of using antibiotics only when required. 
 
1.9.1 Vaccinations  
Vaccinations have been used with limited efficacy as a preventative measure against 
bovine mastitis (Mamo et al., 1994; Giraudo et al., 1997). It is unlikely that a 
multipurpose vaccine will be created to make dairy cows completely resistant to all 
forms of mastitis, due to the plethora of causal agents, and the constantly changing 
genomes of the bacteria. The goal of vaccination research is to create an immunization 
schedule to protect cows against a range of isolates of one pathogen because multiple 
strains can be present within a dairy herd and individual cows (Blowey and 
Edmondson, 2010). Each vaccine will need to be tailored to the specific isolates 
present in a particular region or country. In one study, vaccines created for S. aureus 
produced variable results, depending on the age of the cow and the environmental 
conditions (Giraudo et al., 1997). S. aureus vaccines derived from bacterins 
(attenuated bacteria) have been shown to be less protective than vaccines derived 
from DNA and recombinant protein (Middleton et al., 2009). There are mastitis-causal 
agents such as Klebsiella pneumonia, a Gram-negative rod-shaped bacterium, for 
which a vaccine has not been developed yet (Middleton et al., 2009). An example of 
a successful vaccine is the Escherichia coli J5 vaccine, which reduced the incidence 
of infection by 70-80% in the targeted herd (Middleton et al., 2009). There is a range 
of vaccines that are no longer effective due to strain recombination and the emergence 





1.9.2 Nanoparticles  
Nanotechnology has led to the development of nanosized antibacterial particles that 
have demonstrated elevated interactions with bacteria when compared to 
microparticles (Dehkordi et al., 2011). These particles enter cells more readily and 
have an increased surface area ratio (Dehkordi et al., 2011). The literature documents 
research to augment antibiotics with nanoparticles that had an increased efficacy in 
mastitis therapy. Dehkordi et al. (2011) showed that silver nanoparticles, used in 
combination with antibiotics, inhibited protein synthesis and had a synergistic effect 
against S. aureus. Wang et al. (2012) illustrated the stand-alone properties of 
tilmicosin-solid lipid nanoparticles as a therapy against S. aureus. In addition to the 
low cost of manufacturing this product (Dehkordi et al., 2011), antimicrobial agents 
encapsulated in nanoparticles shows promise as a commercial product for the 
management of bovine mastitis.  
 
1.9.3 Cytokines 
Cytokines are proteins manufactured during the signalling of an immune response 
(leukocyte recruitment and activation) in the presence of an infection and have been 
linked to stimulating acquired immunity in the mammary glands (Bradley, 2002). 
Literature shows that cytokines cannot trigger complete bovine immunity against 
mastitis. However, when administered in conjunction with antibiotics, there was a 
synergistic effect documented against a bovine S. aureus infection (Bradley, 2002).  
 
1.9.4 Plant-Derived Antimicrobials  
Plant-derived molecules and extracts have been found to have antimicrobial properties 
with the advantage of not inducing resistance after prolonged use (Baskaran et al., 
2009). Baskaran et al. (2009) demonstrated in-vitro, that plant-derived molecules 
trans-cinnamaldehyde, eugenol, carvacrol and thymol were effective against five 
bovine mastitis causal agents, S. agalactiae, S. dysgalactiae, S. uberis, S. aureus, 
and E. coli. These plant-derived molecules were classified as safe by the United States 
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Food and Drug Administration and it was suggested that these molecules could be 
used as adjunctive therapy with antibiotics (Baskaran et al., 2009).  
 
1.9.5 Animal-Derived Antimicrobials 
Lactoferrin is an immunomodulator naturally secreted by mammals, that is found in 
the saliva, tears, bronchial mucus and milk (Kutila et al., 2003). Kutila et al. (2003) 
demonstrated the antimicrobial properties of lactoferrin against mastitis causal agents 
E. coli, S. aureus, coagulase-negative staphylococci, Pseudomonas aeruginosa and 
K. pneumonia. A They also showed that a combination of β-Lactoglobulin (naturally 
occurring in whey protein) and lactoferrin had synergistic activity against S. aureus. 
These proteins are not commercially available as antimicrobials, but further research 
may result in the development of animal-derived antimicrobial therapies. 
 
1.10 Phages  
Phages are naturally occurring viruses that are a part of the microbial ecosystem, with 
the natural environment containing billions of phages (Chanishvili et al., 2001; Garcia 
et al., 2009). Phages have specific bacterial hosts and can infect bacteria without 
harming the plant or animal host of the bacterium (Fischetti, 2005). Unlike broad-
spectrum antibiotics, phages also have no detrimental effect on mammalian cells 
(Jassim and Limoges, 2014). In developing a phage therapy, target phages are 
isolated from the natural environment of the bacterium (Chanishvili et al., 2001; Kelly 
et al., 2011). Then the screening process aims to identify a consistently lytic phage, 
robust enough for commercial use. Phage therapy was used in human medicine from 
the early 1900s but was abandoned in favour of the broader spectrum antibiotics in 
the 1940s (Jassim and Limoges, 2014). However, in Russia, Georgia and Poland 
phage research for use in human medicine has continued to the present day (Jassim 
and Limoges, 2014). The development of antibiotic resistance has increased the need 
to find alternatives to antibiotics. One of the widely researched phage therapies is 
Phagoburn, which was funded by the European Union, where phages are used to treat 
opportunistic bacteria infecting burn wounds (Soothill, 1994; Jassim and Limoges, 
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2014). Bacterial resistance is prevented by applications of cocktails of multiple phages, 
which reduces the probability of bacterial resistance developing to the phages (Jassim 
and Limoges, 2014). Phage therapy can be administered in accordance with the 
infection, either topically, intravenous, or orally (Chanishvili et al., 2001). Once a phage 
therapy is administered, the phages replicate exponentially in hours inside target 
bacteria, unlike the antibiotic counterpart which requires multiple applications 
(Chanishvili et al., 2001). Phages do not produce toxic residues/metabolites after 
treatment, and once the target host is destroyed, the phages will be dispersed 
harmlessly (Kelly et al., 2011). Bacterial resistance is overcome by phages through 
synergistic mutations with the host bacterium in the natural environment (Kelly et al., 
2011). Phages show a very low frequency of triggering an allergic reaction in humans 
and can be administered to humans who are allergic to antibiotics (Chanishvili et al., 
2001). The ability of phages to eliminate an antibiotic-resistant infection was 
demonstrated by Smith and Huggins in 1982. A single administration of a phage to 
treat lethal intramuscularly induced infection of mice with Escherichia coli 
demonstrated greater therapeutic potential to cure the bacterial infection than multiple 
intramuscular doses of tetracycline, ampicillin, chloramphenicol, or trimethoprim plus 
sulphafurazole (Smith and Huggins, 1982). 
 
1.10.1 The Economic Importance of Phage’s  
The latest market report published by Credence Research estimated the 
bacteriophage industry of clinical application, food & beverages, phage display, phage 
therapy, environmental application and veterinary (Credence Research, 2018). To be 
valued at US$ 567.9 Million in 2017 and forecasted to grow by compound annual 
growth rate of 3.9% from 2018 to 2026 (Credence Research, 2018). The Credence 
finical report listed AmpliPhi Biosciences Coperation, EnBiotiz, Phage Biotech Ltd, 
Fixed-Phage Limited, InnoPhage, Ltd., Pherecydes Pharma, TechnoPhage, Lysando 
GmbH and Versatile as the key market players (Credence Research, 2018). The 
largest sector regarding revenue is reported to be food and beverage industry, with 
application of food biocontrol of pathogenic bacteria in ready to eat meals, fruits and 
dairy products (Credence Research, 2018). The geographic distribution of these 
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companies is spread Europe, North America, Asia pacific, Latin America, Middle East 
and Africa (Credence Research, 2018).  
 
1.10.2 Phage Mode of Action  
Phages are further divided by their life cycle into either lytic or temperate (Basdew and 
Laing, 2011). In the lytic cycle, virions inject their genome into bacterial cells, the host’s 
machinery is used to replicate, and the host cells are lysed, releasing the next phage 
generation (Parisian et al., 2008; Madigan et al., 2012).  
Temperate phages differ because the viral genome is either assimilated into the host 
genome or remains as a plasmid in the host (Parisian et al., 2008; Madigan et al., 
2012). Instead of replicating, it stays dormant (prophage). It may remain in this 
prophage state indefinitely, failing to replicate inside the host cell (Parisian et al., 2008; 
Basdew and Laing, 2011). These cells are referred to as lysogenic, having the 
potential of producing lysis (Madigan et al., 2012). Eventually, the prophage host cell 
will enter a lytic cycle of the viral genome replicating and releasing phages (Parisian 
et al., 2008). 
 
1.10.2.1 Absorption  
Phage tails have specialized attachment structures that bind to specific surface 
molecules of a bacterial host (Basdew and Laing, 2011). The receptors of Gram-
negative bacteria vary from oligosaccharides, proteins, teichoic acid and 
lipopolysaccharides (Parisian et al., 2008; Basdew and Laing, 2011). The 
peptidoglycan layer encapsulating Gram-positive bacteria offers multiple binding sites 
(Parisian et al., 2008). Some phages require two different surface molecules to be 
present before binding, due to phage tail attachment receptors (Parisian et al., 2008). 
Bacterial cells may become resistant to strains of phages by changing the structure of 
the surface molecule that a particular phage bind to (Vinodkumar et al., 2005). 
However, phages can compensate by a range of mutations, which adapt the tail fibres 
to recognize the altered surface molecules of the host bacterial cells (Vinodkumar et 




After attachment of phage tail fibres to bacterial surface molecules, the viral genome 
is inserted into the host cell (Parisian et al., 2008). The mechanism of viral genome 
transfer varies among phage species (Elbreki et al., 2014). Enzymatic reactions allow 
the viral genome to pass through the peptidoglycan and membrane layers of the host 
cell (Parisian et al., 2008; Elbreki et al., 2014). The viral genome is then incorporated 
into the host cell genome. This process is largely unknown for most phages (Parisian 
et al., 2008). However, once the viral genome has been injected into the bacterial cell, 
it is subjected to exonuclease and restriction enzymes (Parisian et al., 2008; Elbreki 
et al., 2014). Phages have overcome recognition by these enzymes by altering their 
genetic sequences (Parisian et al., 2008; Elbreki et al., 2014). Sticky ends or terminal 
redundancies allow the sequence to either circularize or remain linear, thereby 
avoiding enzymatic digestion (Elbreki et al., 2014). 
1.10.2.3 Replication  
Phage promoters lead RNA polymerase of the host to recognize phage genes and the 
transcription products restructure the host for the replication of phages (Parisian et al., 
2008; Elbreki et al., 2014). In the process, the phage transcripts deactivate the host's 
cellular functions: macro-molecular biosynthesis, enzymatic action (proteases, 
restriction enzymes) and protein functions (Madigan et al., 2012). Phages either 
encode for their own RNA polymerase or for DNA-binding proteins that reprogram the 
host’s RNA polymerase (Madigan et al., 2012). The next set of phage genes 
transcribed are involved in the synthesis of phage components (Madigan et al., 2012). 
DNA is then packed into the phage structures (icosahedral protein shells), aided by 
scaffolding proteins, after which the phage tails are attached and assembled 
separately (Madigan et al., 2012). Once the phages are assembled, their final step is 
lysis of the host cell (Madigan et al., 2012). Tailed phages use the enzymes lysin and 
holin to exit the host cell (Parisian et al., 2008; Elbreki et al., 2014). Lysin is an enzyme 
that breaks down the bonds in the bacterial peptidoglycan layer (the cell wall) and holin 
is a protein that creates pores in the inner membrane of the bacterial cell, allowing 
lysin enzymes passage through the inner membrane to the cell wall (Parisian et al., 
2008; Elbreki et al., 2014). 
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1.10.3 Phage Characterization  
Phages are prokaryote viruses of one order and are currently subdivided into 17 
families and three floating groups, as listed in Table 1.1 (Ackermann and Prangishvili, 
2012). Phage particles are constituted of a DNA or RNA genome, encapsulated by a 
protein or lipoprotein coat known as the nucleocapsid (Ackermann et al., 2009). The 
genome of phages ranges from thousands of base pairs to 480,000 base pairs 
(Ackermann and Prangishvili, 2012). The largest genome of a phage that has been 
sequenced is Phage G with a genome size of 700kb (Ackermann and Prangishvili, 
2012). Viruses are also differentiated by shape (rods, spherical, lemon-shaped or 
pleiomorphic), and their capsid, genome and lytic abilities (Ackermann et al., 2009; 
Ackermann and Prangishvili, 2012). Over 95% of phages belong to the order 
Caudovirales, which contains three main families, Myoviridae, Siphoviridae, and 
Podoviridae, which are further differentiated by their specific tail morphology (Figure 
1.2) (Ackermann et al., 2009). The other 14 families contain filamentous, cubic and 
pleomorphic phages with single/double-stranded DNA or RNA (Ackermann et al., 
2009). The International Committee on Taxonomy of Viruses uses every set of defining 
characteristic to classify phages (Ackermann et al., 2009; Madigan et al., 2012). The 
taxonomic names are derived from Latin or Greek dialect (Madigan et al., 2012). 
Order, family and genera end in -virales, -viridae and -virus, respectively (Madigan et 
al., 2012). 
Table 1.1 Characteristics of the 17 families and 3 floating groups of phages 
(Ackermann, 2007) 
Shape Nucleic acid Virus group Particulars Example  











Polyhedral DNA, 1, C 
           2, C, S 
           2, L 
           2, L 
           2, C 
RNA, 1, L 









complex capsids, lipids 
inner lipid vesicle, 
pseudotail 











Filamentous DNA, 1, C 
           2, L 




(1) long filaments 







Pleomorphic DNA, 2, C, S 
           2, C, S 
           2, L, S 
           2, C, S 
           2, L         
           2, C 

























C: Circular; L: linear; S: superhelical; seg: segmented; 1: single-stranded; 2: double-














Figure 1.2 Phage shape of each family and floating groups (Ackermann, 2007). 
 
1.11 Diagnosis Methods  
1.11.1 Electron Microscopy Identification 
Electron microscopy (EM) has facilitated research into virus structure, their entry into 
cells and their assimilation during replication (Ackermann and Prangishvili, 2012). This 
technique is used globally for the diagnosis and pathogenesis studies of viruses 
(Ackermann and Prangishvili, 2012).  
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For diagnostic purposes, this technique is less reliable when the virus particles are 
present in low concentrations in the host. This limiting factor is circumvented by 
artificial bulking of the virus before viewing samples (Ackermann and Prangishvili, 
2012). In cases of viruses being difficult to locate in samples, an immunosorbent 
electron microscopy technique is used which employs serology to aggregate virus 
particles (Madigan et al. 2012). Grids are coated with the corresponding antibodies of 
the virus that increase the sensitivity and selectivity of virus particles present (Madigan 
et al. 2012). 
The added benefit of EM is seen when identifying unknown virus particles because no 
organism specific reagents are required, unlike other serological tests that require 
specific probes to identify the presence of a virus (Madigan et al. 2012). This is helpful 
because serological identification is not available for all phages. The detection and 
differentiation of different particles have been successfully accomplished for different 
phage families (Ackermann and Prangishvili, 2012). Viral families such as Myovridae, 
Siphoviridae and Podoviride in Figure 1.2 have easily distinguishable virus particles 
due to their distinct particle morphology (Ackermann and Prangishvili, 2012). 
 
1.11.2 Genomic Identification of Pathogens  
Molecular techniques for pathogen identification started to be developed in the late 
1980s with the development of DNA amplification techniques used to identify disease-
causing pathogens (Clarridge, 2004). The amplification of conserved regions of DNA 
allowed for the identification and differentiation of pathogens down to the species level 
(Janda and Abbott, 2007). Conserved regions of DNA are part of an organism’s 
genetic code that is generally similar or identical sequences in nucleic acids (DNA and 
RNA) across species (Janda and Abbott, 2007).  The development of the 16s rRNA 
primers has allowed for a useful means of DNA amplification identification, due to the 
highly conserved nature of this gene (Woo et al., 2008). The 16s rRNA gene is used 
because of its existence in most, but not all, bacterial species (Woo et al., 2008). The 
gene function has not changed, hence, random variations in the sequence can be 
used as evolutionary markers (Woo et al., 2008).  
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Growing amount of DNA sequencing data is being shared globally due to 
advancements in genomic technology. Highly conserved regions within given taxons 
have been coded, allowing for more specific primer selections to differentiate between 
isolates within the species level (Janda and Abbott, 2007; Woo et al., 2008). Viruses 
are genetically different from bacterium because they do not appear to have universal 
conserved regions and therefore “universal” primers cannot be developed for viral 
identification (Clarridge, 2004; Janda and Abbott, 2007). Specific primers are required 
for different classes of viruses because their conserved regions vary (Clarridge, 2004; 
Janda and Abbott, 2007).   
Today DNA amplification (polymerase chain reaction) is used in conjunction with 
microbial culturing, microscopy and serological tests using antigen detection 
techniques. This is due to the lack of broad-spectrum primers used on pathogens 
outside of the bacterial order. An example of this is viruses with little to no conserved 
genetic material due to recombination and mutation of genomic material, which is 
increasing evident with RNA viruses (Clarridge, 2004).  
Whole genomic sequences not only allow for the identification of a virus but also reveal 
the mutations and evolutionary changes of a virus (O'Flaherty et al., 2018). Due to the 
relatively small genomes of phages (thousands of base pairs to 480,000 base pairs) 
(Ackermann and Prangishvili, 2012), whole genome sequences of phages will be 
relatively easy to work with within statistical models (O'Flaherty et al., 2018). 
Polymerase chain reactions (PCR) has been the most commonly used virus detection 
method, as opposed to the whole genome sequencing (Next generation sequencing 
(NGS) (O'Flaherty et al., 2018), by amplifying a segment of the virus genome that is 
common to strains of a genus and comparing it to known DNA sequences from the 
National Center for Biotechnology Information (NCBI). An open source statistical 
package called the Basic Local Alignment Search Tool (BLAST) can then be used to 
identify sequence similarities with reference sequences on the NCBI database, 




1.12 Conclusion  
The inevitable evolution of antibiotic-resistant pathogens has led to an increasingly 
search for viable alternatives to antibiotic therapy for the treatment of bovine mastitis.  
Phages may have a role to play as a supplement of antibiotic therapy to manage 
bovine mastitis. Phage therapy was being developed in 1900 but was largely 
abandoned in favour of antibiotics in western countries when antibiotics became 
widely available in the 1940’s. Currently, publications documenting the versatility and 
safety of phage therapy have been increasing in frequency every year. This is evident 
with the International Committee on Taxonomy of Viruses documenting the discovery 
of novel phage families of approximately 100 novel phages a year (Ackermann, 2007). 
Phages may not replace antibiotics immediately but may work as adjunctive therapy 
with antibiotics to increase the efficacy of treatment of mastitis. It also shows promise 
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Screening Streptococcus uberis strains isolated from dairy farms in KwaZulu-
Natal, RSA for antibiotic resistance using the Kirby Bauer disc diffusion 
method 
 
Antibiotic-resistant bacteria are recognized as a major public threat due to the 
recorded 2 million people infected yearly in the USA, with a minimum of 23,000 
fatalities. In developing countries livestock production accounts for the bulk of 
antibiotic use, claiming 50-80% of consumption. Tracking the incidence of 
antibiotic resistance in mastitis-causing bacteria would be useful for the South 
African dairy industry. The aim of this chapter was to identify resistant S. uberis 
strains to access the phage therapy efficacy in chapter 3.  Eleven strains of 
bacteria that were potentially identified as S. uberis, subsequently they were 
screened using 16s ribosomal RNA sequencing. Six strains were identified as 
S. uberis. These strains were screened against 8 antibiotics commonly used in 
the dairy industry and vancomycin. Using the Kirby Bauer method and The 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical 
breaking points zone diameters, version 10.0, 2020. Of the following antibiotic 
families: β-lactam (ampicillin, penicillin G, cefalexin, oxacillin and amoxicillin), 
macrolides (erythromycin), tetracyclines (tetracycline) and glycopeptide 
(vancomycin). Strain 21A was resistant to 7 of the test antibiotics. All the strains 
were susceptible to vancomycin, which is not available for intra-mammary 
infections. Resistance to the 7 other antibiotics varied amongst the strains. The 
study was based on mastitis strains isolated from KZN, submitted by farmers. It 
represented only those who could afford veterinary diagnostics from Allerton 
Laboratory. This was not a survey study but an identification of resistant strains 





2.1 Introduction  
The emergence of antimicrobial resistance has become a prominent feature on the 
international agenda of human and veterinary health (WHO, 2014). Antibiotics are 
produced by microorganisms as secondary metabolites to alleviate the competition for 
a food source in their natural environment (Marinho et al., 2016). Currently, antibiotics 
are found in the environment at abnormal levels relative to the sub-inhibitory quantities 
naturally present (Goh et al., 2002). In an ecosystem, apart from bacterial inhibition, 
antibiotic molecules trigger gene transfer, intra-chromosomal recombination, stress 
responses, biofilm formation and phage introduction, thus acting as signal molecules 
(Goh et al., 2002; Yim et al., 2007; Baquero et al., 2013).  
In developing countries, livestock production accounts for most of the antibiotic use, 
with 50-80% of antibiotic consumption (Cully, 2014). Subsequently, the antibiotics 
enter the environment via effluent discharge, manure and sewage run-offs (Marinho 
et al., 2016). Similarly, the use of antibiotics on humans results in a release of 
antibiotics into the environment, wastewater systems, and then into large aquatic and 
marine systems (Marinho et al., 2016). 
Resistance has developed because antibiotics are not fully metabolized in food 
production, and veterinary and human use, and are subsequently released into the 
environment, where selection for resistance takes place (Sarmah et al., 2006). Studies 
have documented bacterial cells possessing resistance to all classes of antibiotics 
prescribed, pre-empting the development of conservative antibiotic therapies (Cully, 
2014; Marinho et al., 2016). The WHO is leading the appeal to governments and 
private institutions to acknowledge the antibiotic resistance epidemic resulting from 
overuse, and unregulated use worldwide (WHO, 2014). However, the emergence of 
antibiotic resistance is a natural consequence of evolution and is a function of the 
selection pressure imposed on bacteria (Marinho et al., 2016). 
Micro-organisms are capable of horizontal gene transfer of resistance to 
phylogenetically distant species (Gillings and Stokes, 2012). They are also capable of 
transmitting resistance between different hosts in a multitude of ecosystems (Couce 
and Blázquez, 2009). The long-term consequences of releasing these antimicrobial 
resistant bacteria into the environment cannot be predicted without detection 
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programmes administered by governmental structures (Marinho et al., 2016).  The aim 
of this chapter was to identify resistant S. uberis strains present in KwaZulu-Natal 
(KZN) to access the phage therapy efficacy in chapter 3.  
 
2.2 Materials and methods  
2.21 Streptococcus uberis identification and isolation  
From June 2017 to February 2018, S. uberis strains isolated by Allerton Provincial 
Veterinary Laboratory from unpasteurized milk samples. On request of dairy farmers 
in the KZN region for total bacterial counts and bacterial identification analysis. Strains 
were subcultured onto blood agar and delivered to the University of KwaZulu-Natal 
laboratory. Allerton’s laboratory identified S. uberis using the following tests: gram 
reaction, haemolysis patterns on blood agar, catalase reactions using hydrogen 
peroxide (5%), CAMP test (Christie-Atkins-Munch-Peterson) and an esculin hydrolysis 
as per their inhouse standard operating procedures. 
The identity of the strains were then confirmed by sequencing of the 16s ribosomal 
RNA by Inqaba Biotechnical Industries (Pty) Ltd.  
Genomic DNA was extracted from the cultures received using the Quick-DNA™ 
Fungal/Bacterial Miniprep Kit (Zymo Research, Catalogue No. D6005). The 16S target 
region was amplified using OneTaq® Quick-Load® 2X Master Mix (NEB, Catalogue 
No. M0486) with the primers 16S-27F and 16S-1492R. The PCR products were run 
on a gel (Appendix A) and gel extracted with the Zymoclean™ Gel DNA Recovery Kit 
(Zymo Research, Catalogue No. D4001). The extracted fragments were sequenced in 
the forward and reverse direction (Nimagen, BrilliantDye™ Terminator Cycle 
Sequencing Kit V3.1, BRD3-100/1000) and purified (Zymo Research, ZR-96 DNA 
Sequencing Clean-up Kit™, Catalogue No. D4050). The purified fragments were 
analysed on the ABI 3500xl Genetic Analyzer (Applied Biosystems, ThermoFisher 
Scientific). CLC Bio Main Workbench v7.6 was used to analyse the generated 
sequences by the ABI 3500XL Genetic Analyzer and results were obtained by a 
BLAST search (NCBI). 
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2.22 Antibiotic resistance assay  
The Kirby Bauer diffusion method described by Bauer et al. (1966) was used to screen 
S. uberis strains for resistance against four families of antibiotics commonly used to 
treat bovine mastitis in the dairy industry. The antibiotic families used were β-lactams 
(ampicillin, penicillin G, cefalexin, oxacillin and amoxicillin), macrolides (erythromycin), 
tetracyclines (tetracycline), and glycopeptides (vancomycin). All assays were carried 
out in triplicate (Appendix B), on tryptone soy agar (TSA) (100 mm diameter, 4mm 
agar thickness; pH 7.2) infused with a previously prepared bacterial culture (S. uberis 
in broth, incubated for 36 hours at 37°C). Prior to use, the poured Petri dishes were 
dried in an incubator at 37°C for 60 minutes to evaporate excess moisture. Plates were 
incubated for 36 hours at 37°C. Inhibition zones were measured in millimetres using a 
digital calliper (GS5071522, Mastercraft). Zones of inhibition were averaged 
(Appendix C) and resistance determined according to The European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) clinical breaking points and zone 
diameters, version 10.0, 2020 (EUCAST,2020). Testing was performed at the 
University of KwaZulu-Natal, Pietermaritzburg laboratory.  
 
2.3 Results  
2.3.1 Streptococcus uberis isolation 
From a collection of 26 bacterial isolates (identified as S. uberis) provided by Allerton 
Provincial Veterinary Laboratory, 11 isolates chosen at random and were submitted to 
Inqaba Biotechnical Industries (Pty) Ltd for 16s ribosomal RNA sequencing and 
identification, which revealed that 6 of the 11 strains were S. uberis. The reminder 
sequences were identified as Streptococcus dysgalactiae, Brevibacillus centrosporus, 






Figure 2.1 The disc diffusion method used to screen S. uberis strain 17D for resistance 
against vancomycin (30μg). A zone of 13mm or less would indicate that strain 17D 
was resistant to vancomycin according to EUCAST, version 10.0, 2020. 
 
The measurements of the zone of inhibition were measured in millimetres to the 
second decimal point using a digital calliper, as illustrated in Figure 2.1.B. Zones of 
inhibition were rejected on the following basis: overlapping of zones, distortion of 
zones (irregular shape) and irregular growth of bacterium being screened. Figure 2.1.A 
illustrates a typical example of an acceptable zone of inhibition with a distinct 
circumference and even bacterial growth. 
 
2.4 Discussion  
Antibiotic resistance is a global problem including South Africa. It threatens health care 
of humans and animals in the control of bacterial infections. Strategies to manage it 
include tracking trends of shared resistance, identifying evolving resistance genomic 
resistomes, creating a freely accessible data base of resistomes and alerting of 
appropriate authorities (health care professionals) of epidemic levels of cases of novel 
resistance to previously effective antibiotics (Jones, 1999; Marinho et al., 2016).  
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Addressing the problem of zoonotic pathogens, such as methicillin-resistant 
Staphylococcus aureus (MRSA) in the global public health arena requires the 
integration of all stakeholders in an interdisciplinary collaboration (Chang et al., 2003). 
Resistant genetic material can be shared or acquired in an environment by bacteria, 
including via horizontal transfer between species and genera (Marinho et al., 2016). 
Resistant bacteria act as reservoirs of resistant genes for other bacteria, exacerbating 
a pre-existing problem (Grundmann et al., 2006). Hence, the classifying of the 
resistome is essential for the control of antibiotic-resistant causal agents of mastitis 
(Marinho et al., 2016). New resistance may emerge from gene deletions, gene gains, 
gene duplication, genomic sequence rearrangements, gene transfer and other 
chemical signals that alter sequences at the nucleotide level (Grundmann et al., 2006). 
The emergence of multidrug-resistant pathogens is becoming more frequent across 
all industries that use antibiotics, which includes food and agricultural production, and 
human and animal medicine (Marinho et al., 2016). The WHO has identified multidrug 
resistance in Staphylococcus aureus, Escherichia coli, Salmonella spp., and 
Enterococcus spp. as a global concern (Grundmann et al., 2006; ECDC, 2013; WHO, 
2014).  
In the current study, resistance was found to 3 of the 4 families of antibiotics tested. 
Two strains were resistant to tetracycline, which may be related to similar resistance 
found in E. coli and enterococcal species predominantly found in the wild (Marinho et 
al., 2016). These results also correlate with a European Union report in 2013, based 
on data from 25 countries, that tetracyclines were the most purchased antibiotic class 
in the food production industry (European food safety authority and European centre 
for disease prevention and control, 2016). The current study also found ampicillin 
resistance in two of the six strains, unlike other studies that have found widespread 
resistance to this broad-spectrum antibiotic (Sayah et al., 2005). Due to the low 
number of isolates screened, a generalized deduction cannot be made for the region.   
Vancomycin is an antibiotic used as a last resort to treat problematic bacterium such 
as methicillin-resistant S. aureus, yet its widespread use has led to the emergence of 
vancomycin resistance in S. aureus, with the gene responsible being vanA (Chang et 
al., 2003). The elimination of resistance genes from the environment is not possible. 
Theoretically, it would be desirable to prevent the creation of new resistance genes in 
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target bacteria and to limit the spread of current resistant genes into production 
environments, which would require surveillance/screening for resistance, reduced use 
of antibiotics that induce bacterial mutations, and the reduction of antibiotic-rich 
environments that currently allow for the horizontal transfer and recombination of 
genes, and the suppression of phenotypic resistance traits (Wright, 2009). This 
combination of requirements is complex and unlikely to occur in practice, so the 
development of antibiotic resistance is inevitable if correct udder management 
practises are not followed. 
The current strategy to deal with antibiotic resistance is through the discovery of novel 
antimicrobial treatments. However, this has been unsuccessful due to the speed of 
resistance development, and the slow pace of discovery and registration of new 
antibacterial compounds, and the huge costs of novel drug registrations (Couce and 
Blázquez, 2009: Wright, 2009). Stopping the use of certain antibiotics for a period 
appeared to be a solution, but this was disproved in Sweden where E. coli resistance 
to trimethoprim was reported, followed by removal of the compound for two years 
(Brolund et al., 2010). However, this did not reduce the frequency of occurrence of the 
resistant gene dfr, and dissemination of the gene still occurred with co-selection 
occurring with other genes. Thus, antibiotic resistance will keep evolving to attain 
resistance to more and more antibiotics (Brolund et al., 2010). 
Going forward, future studies could include sequencing the predominant strains of S. 
uberis determining the actual genes responsible for the antibiotic resistance. Bryan et 
al. (2014) showed that there are a multitude of genes that can be responsible for 
resistance to tetracycline, with three documented mechanisms: enzymatic inactivation 
of the antibiotic, efflux pump and ribosomal protection. Identifying the resistant genes 
present and the resistance mechanism could allow for strategic countermeasures to 
avoid multidrug resistance. The use of antibiotics in agriculture may have 
unprecedented consequences, and further studies are required to identify resistance 
patterns and genes present in the microbial community to moderate the conditions 
that lead to resistance.  Identifying the resistant genes present and the resistance 
mechanism would allow for an understanding of the process and scale of multidrug 
resistance. The use of antibiotics in agriculture may have unprecedented 
consequences, and further studies are required to identify resistance patterns and 
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genes present in the microbial community to model the future development of 
resistance and to develop contingency plans for a future where there are few, if any, 
effective antibiotics. 
The shortcomings in this report, the study was based on mastitis cases from KZN 
reported by farmers. It represented only those who could afford veterinary diagnostics 
from Allerton Laboratory. With 6 strains being evaluated and these findings are not 
generalizable to the entire region or country. This was not a survey study but an 
identification of resistant strains to challenge the phage therapy efficacy. Animals that 
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Biological and pathogenicity assays of phages specific for Streptococcus 
uberis strains, associated with bovine mastitis 
 
Mastitis is the most economically important disease to dairy herds worldwide, 
with losses arising from decreased milk production, and increased veterinary 
bills and culling. Studies in sub-Saharan Africa revealed that at least 50% of 
dairy cows were infected. The current study isolated six Streptococcus uberis 
phages and then and characterized for the following parameters: phage titre, 
host range, single step growth phase and lethal dose activity. Approximately 
2,000 mastitic milk samples were screened for phages, from which 95 phages 
were isolated. This number was reduced by screening down to 5 phages, 
Phages Numbers CP1, 2, 76, 79 and 80. Phages CP1, CP2, CP76, CP79 and CP80 
produced titres of 59x102, 56x105, 47x106, 50x104 and 35x104 pfu.ml-1, 
respectively. In the strain susceptibility assay there was considerable 
specificity between the phages and strains of S. uberis. One strain of S. uberis 
was susceptible to all five phages, whereas Strains 17D and 78B were not 
susceptible to any of the five phages. Phage CP2 was virulent to four of the six 
S. uberis strains. A single step growth assay illustrated that the cyclic 
replication of the isolated phages took between 50 and 60 minutes. In the lethal 
dose assay, Phages CP1 and CP2 were each able to reduce S. uberis counts by 
86% and 83%, respectively. Of the 5 phages screened, Phages CP1 and CP2 
showed significant potential as a stand-alone treatment. However, Phages 
CP76, CP79 and CP80 would offer sufficient control in a phage cocktail. 
 
3.1 Introduction  
Bovine mastitis is an inflammation of the parenchyma of mammary glands of dairy 
cows (Jones and Bailey, 2009). The symptoms comprise of physical and chemical 
changes of the glandular tissue and of milk, adversely affecting the cow’s health and 
quality of milk (Blowey and Edmondson, 2010). The bacteria causing bovine mastitis 
are usually located on the teats of the cow, which then serve as a reservoir of infection 
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from which to spread from one cow to the next during milking, or they are introduced 
to the teats of the cow from the environment (Blowey and Edmondson, 2010). 
S. uberis is extremely versatile and able to survive in various areas of the cows, mouth, 
vulva, groin and axilla (Almeida et al., 2006; Blowey and Edmondson, 2010). The 
bacterium has been identified as an environmental pathogen and is found in the 
bedding (straw and sand), pastures and faeces (Almeida et al., 2006; Blowey and 
Edmondson, 2010). S. uberis is the most common pathogen causing environmental 
mastitis in most countries, due to its poor opsonization in the presence of casein 
protein and its ability to exist inside cells, which means that it is protected from 
antibiotics (Hillerton and Kliem, 2002). 
Phage therapy researched as a biological control, targets a specific strain of bacterium 
and is harmless to the host and beneficial bacterium (Basdew and Laing, 2011). 
Phages are naturally occurring viruses that are a part of the microbial ecosystem, with 
the natural environment containing billions of phages (Chanishvili et al., 2001; Garcia 
et al., 2009). Numerous phage applications on food items are currently being 
developed for commercial use (Sofos, 2008). A Salmonella phage treatment has been 
commercialized to control growth of Salmonella on cooked and raw beef (Sofos, 
2008). Such applications of phages as a biocontrol strategy is set to become an 
increasingly common practice in the global food industry. 
The aim of this chapter was to isolate phages of S. uberis and then to characterize 
them for the following parameters: phage titre, host range, single step growth phase 
and lethal dose activity. This in vitro study was an essential step towards phage 
therapy against South African strains of streptococcal etiological agents of bovine 
mastitis.  
 
3.2 Materials and methods  
3.2.1 Streptococcus uberis identification and isolation  
From June 2017 to February 2018, S. uberis strains isolated by Allerton Provincial 
Veterinary Laboratory from unpasteurized milk samples. On request of dairy farmers 
in the KZN region for total bacterial counts and bacterial identification analysis. Strains 
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were subcultured onto blood agar and delivered to the University of KwaZulu-Natal 
laboratory. Allerton’s laboratory identified S. uberis using the following tests: gram 
reaction, haemolysis patterns on blood agar, catalase reactions using hydrogen 
peroxide (5%), CAMP test (Christie-Atkins-Munch-Peterson) and an esculin hydrolysis 
as per their inhouse standard operating procedures. 
The identity of the strains were then confirmed by sequencing of the 16s ribosomal 
RNA by Inqaba Biotechnical Industries (Pty) Ltd (http://www.inqababiotec.co.za).  
Genomic DNA was extracted from the cultures received using the Quick-DNA™ 
Fungal/Bacterial Miniprep Kit (Zymo Research, Catalogue No. D6005). The 16S target 
region was amplified using OneTaq® Quick-Load® 2X Master Mix (NEB, Catalogue 
No. M0486) with the primers 16S-27F and 16S-1492R. The PCR products were run 
on a gel and gel extracted with the Zymoclean™ Gel DNA Recovery Kit (Zymo 
Research, Catalogue No. D4001). The extracted fragments were sequenced in the 
forward and reverse direction (Nimagen, BrilliantDye™ Terminator Cycle Sequencing 
Kit V3.1, BRD3-100/1000) and purified (Zymo Research, ZR-96 DNA Sequencing 
Clean-up Kit™, Catalogue No. D4050). The purified fragments were analysed on the 
ABI 3500xl Genetic Analyzer (Applied Biosystems, ThermoFisher Scientific). CLC Bio 
Main Workbench v7.6 was used to analyse the generated sequences by the ABI 
3500XL Genetic Analyzer and results were obtained by a BLAST search (NCBI). 
 
3.2.2 Phage isolation, propagation and purification 
During the period of June 2017 to February 2018 approximately 2000 milk samples 
were screen for phages. Weekly samples of milk were collected from Allerton 
laboratories which have been submitted by dairy farmers in the KwaZulu-Natal region 
for testing. Milk samples were collected by the farmers using aseptic techniques and 
transported to Allerton via cold storage, samples were screened for the requested 
tests and only samples identified as mastitic by Allerton were submitted to UKZN 
laboratories for the following study. 
Milk samples were tested using the double-layer spot-plate technique for each S. 
uberis strains isolated (Sambrook et al., 1989). Overnight S. uberis cultures were 
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incorporated into 0.7% top agar of a double-layer plate and supplemented with 1M 
CaCl2. Raw milk was then spotted onto the surface of solidified top agar at 10μl per 
spot. Plates were allowed to dry for 2hr and then incubated at 37ºC x 36hr. Zones of 
clearing (plaques) were indicative of phage lytic activity. Plaques were removed and 
soaked in a 40% glycerol solution at 20ºC x 12hr with gentle agitation at 150rpm.  The 
suspension was then centrifuged at 10,000g x 10min at 4ºC, and the supernatant was 
filtered using a 0.45μm syringe filter and stored as phage stock at 4ºC.  
 
3.2.3 Phage titre  
Phages were titred for each S. uberis strain isolated, using the double-layer spot-plate 
technique as described by Deininger, (Deininger, 1990). Overnight S. uberis cultures 
were incorporated into 0.7% top agar supplemented with 1M CaCl2. For each phage, 
dilution series (100 to 10-10) were prepared and incorporated into the top agar. Plates 
were allowed to dry for 2hr and then incubated at 37ºC x 36hr. Zones of clearing 
(plaques) were indicative of phage lytic activity. The number of plaque forming units 
per millilitre (pfu.ml-1) was calculated as described by Deininger, (Deininger, 1990) 
where pfu.ml-1 = number of plaques x reciprocal of dilution x dilution factor. 
 
3.2.4 Phage host range analysis 
Host range analysis was carried out using the spot-test method on double-layer plate. 
An overnight culture of each of the 6 S. uberis strains was incorporated into pre-
warmed top agar (0.7%), supplemented with CaCl2. Top agar was immediately poured 
into previously prepared bottom layer agar. Undiluted phage stock was screened 
against the S. uberis species by spotting 10µl droplets of each phage onto the surface 
of the S. uberis inoculated double-layer plate. All plating was carried out in triplicate. 
The plates were left to dry for 2hr followed by incubation for 36hr at 37ºC. Any plates 




3.2.5 Single step growth curve 
The protocol was carried out according to Harley and Prescott (1993). Phage stock 
solution was made up to a 10-1 dilution in 9.9ml of tryptone soy broth (TSB). Then 100 
µl of S. uberis strain 21A was added to the TSB phage mixture and incubated at 37ºC 
with gentle agitation (150rpm). The control treatment consisted of 9.9ml TSB + 100 µl 
of S. uberis. Following 25 minutes of incubation, and at 5 minute intervals until 60 
minutes (25min, 30min, 35min, 40min, 45min, 50min, 55min and 60min), 1ml of the 
TSB mixture was aliquoted into pre-warmed top agar (0.7%) of a double-layer plate 
supplemented with CaCl2  and inoculated with an overnight culture of S. uberis strain, 
21A. Top agar was immediately poured into the previously prepared bottom layer agar. 
Plates were allowed to dry for 2hr and then incubated at 37ºC x 36hr. Zones of clearing 
(plaques) were indicative of phage lytic activity. The number of plaque forming units 
per millilitre (pfu.ml-1) was calculated as described by Deininger, (Deininger, 1990), 
pfu.ml-1 = number of plaques x reciprocal of dilution x dilution factor.  
 
3.2.6 Lethal dose assay 
An overnight culture of S. uberis strain, 21A, was prepared in TSB and 50ml each was 
aliquoted to six sterile conical flasks. Bacterial cell counts per millilitre were determined 
after overnight incubation. Thereafter, each flask was inoculated with 5ml of the six 
phage stock solutions (Phages CP1, CP2, CP76, CP79 and CP80) and incubated for 
24hrs at 37ºC. After incubation, live bacterial cell counts were determined using 
dilution plating. 
 
3.3 Results  
3.3.1 Streptococcus uberis and phage isolation 
Eleven strains of S. uberis were isolated and identified. The identity of the 11 strains 
were then genetically confirmed by sequencing the 16s ribosomal RNA, which 
revealed that the six of 11 strains were S. uberis (4B, 78B, 21A, 17D, 15D and 31C). 
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Approximately 2,000 mastitic milk samples were screened for phages, from which 95 
phages were isolated. From these, five test phages were selected for their activity. 
 
3.3.2 Phage titre  
Phages CP2 and CP76 produced higher plaque counts than the phages CP1, CP79 
and CP80, suggesting that they are more virulent in nature. Plaque counts were 
attained at different dilution factors of the five phages screened, Phages CP1, CP2, 
CP76, CP79 and CP80 produced titres of 59x102, 56x105, 47x106, 50x104 and 35x104 
pfu.ml-1, respectively. Phage CP1 produced the lowest phage titre and Phage CP76 
produced the highest titre, demonstrating a difference in their replication and virulence. 
Acceptable plaque counts were between 20 and 90 plaques per plate.  
 
3.3.3 Host range analysis  
Zones of clearing (plaques) were indicative of phage lytic activity, whereas the 
absence of a plaque was indicative of no virulence by the phage to that strain of S. 
uberis. S. uberis 21A was susceptible to the five test phages (Table 3.1). In contrast, 
Strains 17D and 78B were not susceptible to the five phages. Phage CP2 possessed 







Bacterial titre before phage represents the initial S. uberis bacterial counts without 
phage addition and bacterial titre after phage refers to the addition of Phages (CP1, 
CP2, CP76, CP78 and CP80) and 24-hour incubation. Phages CP1, CP2, CP76 and 
CP80 reduced the initial bacterial counts by greater than half the original bacterial 
count (Figure 3.2). 
 
Table 3.2 Reduction in live bacterial cell count after addition of phages to S. uberis 
Strain 21A, relative to the control illustrated in Figure 3.2. 
 
Phages 1 and 2 caused the highest reduction of live bacterial cells, 86 % and 83%, 
respectively, over a 24-hour period.  
 
3.4 Discussion  
Mastitis is a complex disease involving various factors and identifying the main 
pathogens and risk factors is fundamental to developing preventive and control 
measures (Harding, 1995; Van den Borne, 2010). S. uberis is capable of both clinical 
Phage 
Percentage reduction in the growth of S. 
uberis (Strain 21A) cells 
Phage CP1 86 % 
Phage CP2 83 % 
Phage CP76 41 % 
Phage CP79 57 % 
Phage CP80 48 % 
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and subclinical infections of the cows (Almeida et al., 2006). The cows are constantly 
exposed to S. uberis due to the ubiquity of the pathogen and once infected the 
pathogen may elicit a contagious infection (Almeida et al., 2006).  S. uberis has been 
documented to show little responsiveness to antibiotic treatments (Burvenich et al., 
2003; Blowey and Edmondson, 2010). Use of antibiotics in the treatment of mastitis 
increases the probability of creating antibiotic-resistant strains requiring alternative 
therapies (Mangili et al., 2005; Shi et al., 2010). One such measure is the use of 
biological control to treat mastitis, specifically the use of phage therapy to treat 
pathogenic bacterial infections (Garcia et al., 2009; Basdew and Laing, 2011). 
The five phages in the current study were selected based on their consistent lytic ability 
after multiple sequential generations. These five phages were assessed for their ability 
to lyse mastitis-causing strains of S. uberis isolated from raw milk in the following 
assays: phage titre, host range assay, single strep growth phase and the death phase.  
In the phage tire assay, a range of titres were produced by the five phages ranging 
from 59x102 to 47x106 for Phages CP2 and CP76, respectively. 
The host range analysis revealed a differential interaction between the phages and 
the strains of S. uberis. Whereas Strain 21A was susceptible to all five phages, Strains 
78B and 17D were not susceptible to any of the test phages. Phage CP2 was lytic on 
four of the six strains of S. uberis. 
The single step growth assay tracked the replication cycle of the phages. At the start 
of the assay the pfu.ml-1 was constant, but at 30 to 35 minutes, an exponential increase 
in pfu.ml-1 occurred. Results suggested that after 50-60-minutes of incubation, phages 
lyse their hosts and are released (Gong et al., 1996). 
In the lethal dose assay, Phages CP1 and CP2 were able to reduce S. uberis counts 
by 86% and 83%, respectively, over 24 hours, suggesting that a cocktail of phages 
may offer a more comprehensive therapeutic solution to an S. uberis bovine infection.  
Of the 5 phages, Phages CP1 and CP2 showed significant potential as a stand-alone 
treatment. However, Phages CP76, CP79 and CP80 could  be combined in a phage 
cocktail to increase their activity, and to  broaden the host range of the therapy. Further 
characterization of the phages durability is required for the purposes of commercial 
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production. Sensitivity to variations in temperature and pH, and to chloroform and 
glycerol should be evaluated for each phage. Knowledge of the genomic identity of the 
phages would also be useful. Following the durability and genomic characterization, 
field trials would be required to evaluate the efficacy of each phage therapy as a 
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Morphological classification of phages specific to Streptococcus uberis, 
associated with bovine mastitis 
 
Phages are viruses that exclusively infect bacterial cells. Phages are ubiquitous 
(found in all biospheres) and are the most abundant organisms on earth. 
Understanding the interaction between phages and their hosts is vital to their 
manipulation for therapeutic conditions. This study morphologically 
characterizes phages specific to S. uberis. Phages were isolated using the 
double-layer agar plate technique from 2,000 screened mastitic milk samples  
farms in KwaZulu-Natal, SA. Phage samples were propagated on S. uberis and 
examined on a transmission electron microscopy (JEOL 1400). Negative 
staining was used to view the virus particles. A virus particle image captured 
illustrated Podovirdae morphology, measured to have a 50-65nm diameter 
icosahedral head and a short tail ranging from 25-35nm in length. With a uniform 
structure observed, the phages isolated may belong to one family.  The distinct 
structure of the phage tails was obscured in majority of the micrographs. 
However, this does not imply that no tail is present. It is probable that due to the 
complexity of the camera colour scaling and the low contrast that had to be 
applied, 2D images of the tail were not clear. Due to the poor quality of 
micrographs obtained attributed to the clumping of phages and cell exudate, 
genomic identification would be required to confirm the identity of these virus 
particles.  
 
4.1 Introduction  
The electron microscope has been used extensively as a diagnostic tool for identifying 
viral agents since the 19th century, with the first (confirmed) visualization of a virus 
performed by Ruska and colleagues Kausche and Pfankuch (Ackermann, 2007). Apart 
from the early visualization of significant viruses such as smallpox, chickenpox, 
poliovirus and gastrointestinal viruses, host and viral interactions were observed, 
leading to the discovery of treatments and prevention of these prior unseen disease 
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agents (Goldsmith and Miller, 2009). In 1976 during the haemorrhagic fever pandemic 
in then Zaire (DRC), the electron microscope was instrumental in identifying the Ebola 
virus (Johnson et al., 1977). Similarly, the Henipavirus was identified microscopically 
during an outbreak in both Asia and Australia (Chua et al., 2007).  
Today, electron microscopy still offers an advantage over serological methods. Viral-
specific reagents are not required for a negative stain, which is particularly applicable 
in the case of unknown or newly discovered viruses, where it would not be possible to 
obtain viral specific probes (Goldsmith and Miller, 2009). The list of viral infections 
presently identifiable solely by the electron microscope includes lymphocytic 
choriomeningitis virus, coronavirus and poxvirus (Bayer-Garner, 2005; Lin et al., 
2004). A wide range of samples can be screened, from bodily fluids (urine, blood, 
spinal fluid, bronchiolar fluid, tears, aspirates) to organ tissue, and samples can be 
prepared within minutes via the negative staining procedure (Ackermann, 2007). 
Although assays such as ELISA and PCR are more sensitive and accurate, both 
require specific reagents and take hours to complete, in comparison to the rapid 
screening offered by electron microscopy. This allows electron microscopy to be a first 
line of diagnosis in time-sensitive circumstances such as bio-terrorism threats, 
terminal illnesses and diseases epidemics (Goldsmith and Miller, 2009). However, 
there are limitations to what the electron microscope can achieve. Viruses cannot be 
identified beyond the family level, and multiple viral infections are troublesome to 
diagnose (Vale et al., 2010).  However, the results derived will allow for accurate 
molecular diagnostic assays to be chosen to identify the virus to a species level 
(Ackermann, 2007; Vale et al., 2010).  
 
4.2 Materials and Methods 
4.2.1 Streptococcus uberis identification and isolation  
From June 2017 to February 2018, S. uberis strains isolated by Allerton Provincial 
Veterinary Laboratory from unpasteurized milk samples. On request of dairy farmers 
in the KZN region for total bacterial counts and bacterial identification analysis. Strains 
were subcultured onto blood agar and delivered to the University of KwaZulu-Natal 
laboratory. Allerton’s laboratory identified S. uberis using the following tests: gram 
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reaction, haemolysis patterns on blood agar, catalase reactions using hydrogen 
peroxide (5%), CAMP test (Christie-Atkins-Munch-Peterson) and an esculin hydrolysis 
as per their inhouse standard operating procedures. 
The identity of the strains were then confirmed by sequencing of the 16s ribosomal 
RNA by Inqaba Biotechnical Industries (Pty) Ltd (http://www.inqababiotec.co.za).  
Genomic DNA was extracted from the cultures received using the Quick-DNA™ 
Fungal/Bacterial Miniprep Kit (Zymo Research, Catalogue No. D6005). The 16S target 
region was amplified using OneTaq® Quick-Load® 2X Master Mix (NEB, Catalogue 
No. M0486) with the primers 16S-27F and 16S-1492R. The PCR products were run 
on a gel and gel extracted with the Zymoclean™ Gel DNA Recovery Kit (Zymo 
Research, Catalogue No. D4001). The extracted fragments were sequenced in the 
forward and reverse direction (Nimagen, BrilliantDye™ Terminator Cycle Sequencing 
Kit V3.1, BRD3-100/1000) and purified (Zymo Research, ZR-96 DNA Sequencing 
Clean-up Kit™, Catalogue No. D4050). The purified fragments were analysed on the 
ABI 3500xl Genetic Analyzer (Applied Biosystems, ThermoFisher Scientific). CLC Bio 
Main Workbench v7.6 was used to analyse the generated sequences by the ABI 
3500XL Genetic Analyzer and results were obtained by a BLAST search (NCBI). 
 
4.2.2 Phage isolation, propagation and purification 
During the period of June 2017 to February 2018 approximately 2000 milk samples 
were screen for phages. Weekly samples of milk were collected from Allerton 
laboratories which have been submitted by dairy farmers in the KwaZulu-Natal region 
for testing. Milk samples were collected by the farmers using aseptic techniques and 
transported to Allerton via cold storage, samples were screened for the requested 
tests and only samples identified as mastitic by Allerton were submitted to UKZN 
laboratories for the following study. Milk samples were tested using the double-layer 
spot-plate technique for each S. uberis strains isolated (Sambrook et al., 1989). 
Overnight S. uberis cultures were incorporated into 0.7% top agar of a double-layer 
plate and supplemented with 1M CaCl2. Raw milk was then spotted onto the surface 
of solidified top agar at 10μl per spot. Plates were allowed to dry for 2hr and then 
incubated at 37ºC x 36hr. Zones of clearing (plaques) were indicative of phage lytic 
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activity. Plaques were removed and soaked in a 40% glycerol solution at 20ºC x 12hr 
with gentle agitation at 150rpm.  The suspension was then centrifuged at 10,000g x 
10min at 4ºC, and the supernatant was filtered using a 0.45μm syringe filter and stored 
as phage stock at 4ºC.  
 
4.2.3 Transmission electron microscopy   
Phage samples were examined using a transmission electron microscopy (JEOL 
1400; https://www.jeolusa.com) according to a procedure described by Vale et al. 
(2010). S. uberis was grown in liquid broth culture (tryptone soy broth) at 37ºC x 24hr. 
The stationary phase culture was then inoculated with the isolated phages and 
incubated further at 37ºC x 36hr. After incubation, 10ul of each sample mixture was 
negatively stained: samples were placed onto a formvar-coated copper grid and air-
dried for 5 minutes, then the grids were stained with a 2% ammonium molybdate 
solution for 5 seconds, rinsed with deionized water for 10 seconds and air dried prior 
to microscopy.  
 
4.3 Results and Discussion  
Due to the nature of the substrate, phage and host bacterium; standard recommended 
negative staining procedures didn’t work. Either the background, bacterial cell or the 
phages were not visible. This required a trial and error adjustment of three stains 
suggested by Hayat and Miller, (1990).  
1. 2% uranyl acetate (UA), UA is the standard choice for virus staining because it 
preserves the virus sample and allows for viewing of the grid weeks after 
staining (Hayat and Miller, 1990). 2% UA was evaluated at 1-second intervals 
from 1 second to 5 seconds, which didn’t offer a clear result of the host 
bacterium, holding too much stain.  
2. Ammonium molybdate (AM), was investigated from solutions 0.5%, 2% and 5% 
and staining intervals of 2, 3, 5 and 7 seconds. The clearest micrographs were 
obtained at 2% AM solution, stained for 5 seconds.  
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3. 2% phosphotungstic acid (PTA), was also tested in an attempt to obtain a better 
image than AM provided. PTA caused interference of the substrate/background 
of the host bacterium and phages in micrographs at 2 seconds and above of 
staining. PTA is not ideal for investigative research as it has been documented 
to degraded virus samples within hours of staining (Hayat and Miller, 1990). 
Each stain (2% UA, 05-5% AM and 2% PTA) was tested in duplicate at the 
aforementioned staining times on phage Phage CP1.  
Of the 95 phages isolated, 30 phages were chosen at random and examined using a 
transmission electron microscopy, this included the 5 phages examined in Chapter 3. 
All micrographs obtained, illustrated similar viral particle structures, which suggested 
the phages screened belong to one family. Thus, the discussion doesn’t differentiate 
the phage strains isolated in chapter 3 and 4, rather an overall discussion of the phage 
identity. 
Phage families are clearly distinguished by their structure, where the head shape can 
be icosahedral, filamentous or pleomorphic, and for the presence or absence of a tail 
(Ackermann, 2005; Goldsmith and Miller, 2009). The tail can either be short or long in 
relation to the head, with the ability to be contractile or non-contractile (Ackermann, 
2005; Goldsmith and Miller, 2009).  
 
Fig. 4.1.A and B is a comparison of healthy and infected S. uberis cells. The healthy S. 
uberis cell in Fig. 4.1.A is firm, round and smooth and distinguishable from a collapsed 






pentamers and icosahedral heads ranging from 60-70 nm in diameter (Ackermann, 
2007; Goldsmith and Miller, 2009). 
 
Figure 4.2 Transmission electron micrograph of phage identified as a N4-podoviruses 
reported by Katharios et al. (2017). 
 
Following TEM observations in Fig 4.2, was classified into the Podoviridae family from 
the analysis of the pVa5 nucleotide sequence using the BLASTn algorithm of the NCBI 
Database Analysis of the pVa5 nucleotide sequence (Katharios et al., 2017). Reported 
by Katharios et al. (2017) to have an icosahedral head measuring 85nm in length and 
a short 25 nm non-contractile tail. This image (Fig 4.2) is similar to the micrographs 
obtained in this study, suggesting virus particles morphology is that of Podoviridae.  
 
A review report in 2007 documented 12 Podoviridae species that were able to infect 
the streptococci species, emphasising the possibility of Fig 4.1.F being 
a Podoviridae species. However, due to the poor quality of micrographs obtained 
attributed to the clumping of phages and cell exudate, genomic identification would be 
required to conform phage identity with certainty (Ackermann, 2007; Goldsmith and 
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5.1 Introduction  
WHO is leading the appeal to governments and private institutions to acknowledge the 
antibiotic resistance epidemic resulting from overuse, and unregulated use worldwide 
(WHO, 2014). Resistance has developed because antibiotics are not fully metabolized 
in food production, veterinary and human use, and are subsequently released into the 
environment, where selection for resistance takes place (Sarmah et al., 2006). The 
rise of antibiotic-resistant pathogens has led to a global search for viable alternatives 
to antibiotic therapies in all industries. A variety of alternative therapies are currently 
available for bovine mastitis including feed formulations, vaccines, antiseptics and 
competitive exclusion products.  
Currently, publications documenting the versatility and safety of phage therapy have 
been increasing in frequency yearly. This is evident with the International Committee 
on Taxonomy of Viruses, documenting approximately 100 novel phage families a year 
(Ackermann, 2007). Phages may not replace antibiotics immediately but may work as 
adjunctive therapy with antibiotics to increase the efficacy of treatment. It shows 
promise as a standalone pre- and post-treatment for bovine mastitis in vivo. 
 
5.2 Major findings and their implications 
The development of an in-vitro phage therapy of the bacterial disease bovine mastitis, 
causal agent S. uberis was the primary goal of this study. This study gathered as many 
S. uberis strains as possibly from milk samples submitted to Allerton by farmers from 
June 2017 to February 2018. From a collection of 26 bacterial isolates from two farms 
(identified as S. uberis) provided and identified by Allerton Provincial Veterinary 
Laboratory according to their standard operating procedures, 11 isolates chosen at 
random and were submitted to Inqaba Biotechnical Industries (Pty) Ltd for 16s 
ribosomal RNA sequencing and identification, which revealed that 6 of the 11 strains 
were S. uberis. It represented only those who could afford veterinary diagnostics from 
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Allerton Laboratory. This was not a survey to establish a level of resistance present 
but a study to identify resistant strains to evaluate the phage therapy efficacy. The 
Kirby Bauer diffusion method described by Bauer et al. (1966). Zones of inhibition and 
resistance determined according to The European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) clinical breaking points and zone diameters, version 
10.0, 2020 (EUCAST,2020). Each S. uberis strain accessed in chapter 2, illustrated 
varied results to the antibiotic screening. Each strain didn’t illustrate resistance to the 
same groups of antibiotics, uniformed results were not obtained although the S. uberis 
strains were obtained from the same region. Note, the sample size was too small to 
draw a conclusion.  
Approximately 2,000 mastitic milk samples were screened for phages, from which 95 
phages were isolated. Five phages were chosen of the initial 95 phages, based on 
their consistent lytic ability after multiple sequential generations. The five phages were 
labelled CP1, CP2, CP76 and CP79. Phage CP1 and CP2 showed significant potential 
as a stand-alone treatment. It is suggested that use of Phages CP76, CP79 and CP80 
in a cocktail would provide good control over a wider strain range of S. uberis.  
Phage samples were propagated on S. uberis and examined in a transmission 
electron microscopy (JEOL 1400). Negative staining was used to view the virus 
particles. All micrographs obtained, illustrated similar viral particle structures 
suggesting the phages screened belong to one family.  A virus particle was measured 
to have a 50-65nm diameter icosahedral head and a short tail ranging from 25-35nm 
in length from the EM micrograph. The phage may belong to the Podoviridae family, 
which are phages characterized by having very short, noncontractile tails. Due to the 
poor quality of micrographs obtained, it is imperative to carry out complete genomic 





5.3 Conclusions and way forward  
Further studies into the genomic sequences of the phages and target bacteria are 
required in order to identify the phages down to a species level and to identify the 
specific mechanisms of resistance used by the S. uberis strains in the dairy 
community. 
The isolated phages showed variable stability in its lytic functions, hence the next step 
to follow this study would be to identify curative dosages, optimal dosages, phage 
cocktail host range, phage cocktail efficacy, the frequency of treatment administration, 
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Appendix A  
 
Figure 1. A photographic image of an agarose gel indicating the amplification of the 
16S target region of the S. uberis strains isolated in chapter 2 (Photograph provided 
by Allerton Provincial Veterinary Laboratory).  
 
Figure 2. A photographic image of an agarose gel indicating the amplification of the 
16S target region of the S. uberis strains isolated in chapter 2 (Photograph provided 











Table 2. Antibiotic resistance screening (Kirby Bauer disc diffusion method) standards 
(millimetres) from the” Antibiotic susceptibility testing by a standardized single disk 
method”, (Bauer et al., 1966). Evaluated using the “The European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) clinical breaking points zone 
diameters”, Version 10.0, 2020. 
Antibiotic Disk Content S≥ I R< 
Amoxicillin 10μg 18 - 18 
Ampicillin 10μg 18 - 18 
Cefalexin 30μg 18 - 18 
Erythromycin 15μg 21 - 18 
Penicillin G 10 units 18 - 18 
Oxacillin 1μg 18 - 18 
Tetracycline 30μg 23 - 20 
Vancomycin 30μg 13 - 13 
S=susceptible to antibiotic, R=resistant to antibiotic, I=intermediate resistance to 
antibiotic  
 
